Company intelligence / Profile preview

Fourier Intelligence

Singapore, Singapore, Singapore

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Fourier is a leading global provider of rehabilitation robotics and general-purpose humanoid robots. Its flagship products include exoskeletons for clinical rehabilitation and the GR-1/GR-2 humanoid robots for assistive and research applications. The company serves over 2,000 organizations and hospitals in more than 40 countries, having launched its first mass-produced humanoid robot GR-1 in 2023 and the next-generation GR-2 in 2024[2][5][7].

Therapeutic areas: Other
Modalities: Device
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on Fourier Intelligence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fourier Intelligence.

Explore the full profile